??
盡管美國并購交易額較去年同比上升47%，但美國對中國公司的收購似乎已跌入谷底，截至目前已跌至6.11億美元，而去年的這個時候這一數字是23億美元，這也創(chuàng)造了12年來的最低水平，Dealogic表示。
問題的部分原因是缺乏大額（超過5億美元）的交易。報告顯示，到目前為止今年還沒有出現這種規(guī)模的交易，而去年，同期已經有兩個這樣的交易，價值13億美金。
但這不僅僅是美國的問題：今年中國的入境并購交易額迄今為止相比去年也少了10%。在“交易活動”的基礎上，情況更為嚴峻的：只有271項協議用來今年購買中國公司，使得中國從國外并購出現從2003年以來最弱的時期，來自Dealogic的報告。
雖然Dealogic的數據沒有提供對在收購美國公司到中國驟降的原因，但同時指出，中國醫(yī)療保健公司的交易值下跌，從去年的11億美元到今年迄今為止的3000萬美元。
報告說，化工部門卻第一次成為美國歷史上有記錄以來購買最有針對性的行業(yè)。
就是說，并購活動的下降似乎預示著更大趨勢的外國資金對中國的流動凍結，根據星期一公布的數據顯示，七月外國直接投資相較去年同期驟降17%。
U.S. companies, and really companies all around the world, are losing interest in buying up their Chinese counterparts, according to a Dealogic report out Friday.
Even as U.S. mergers and acquisitions volume abroad is up 47% year-to-date, American purchases of Chinese companies seem to have fallen off a cliff, dropping to just $611 million so far in 2014, down from $2.3 billion at this time last year, and marking the lowest level in 12 years, Dealogic said.
Part of the problem involves a lack of big ($500 million or more) deals. The report showed no transactions of that size so far this year, while last year, there were already two such deals worth a combined $1.3 billion.
But it’s not just a U.S. issue: China’s total inbound M&A volume year-to-date is 10% less than it was at this time in 2013. And on a “deal activity” basis, the situation is even more stark: There have been just 271 agreements to buy Chinese companies this year, making Chinese M&A from abroad the weakest it’s been since 2003, Dealogic reported.
Although Dealogic didn’t offer a reason for the sudden chill in U.S. acquisitions into China, it did note that deals for Chinese health-care firms plunged from last year — $30 million year-to-date compared to $1.1 billion at this point in 2013.
The chemicals sector, meanwhile, became the most-targeted industry for U.S. purchases for the first time on record, the report said.
That said, the dro-off in mergers activity appears to be part of a larger trend of foreign money cooling to China. Data out Monday showed foreign direct investment plummeting 17% in July from a year earlier.
